Browsing by Author "Samadzade, Ulvi"
Now showing 1 - 20 of 37
- Results Per Page
- Sort Options
Article Autoimmune Thyroiditis and Its Impact on the Clinical Course of Multiple Sclerosis: a Retrospective Cohort Study(Elsevier Sci Ltd, 2025) Kaya, Ergi; Samadzade, Ulvi; Zengin, Ela Simay; Ozakbas, SerkanIntroduction: Autoimmune thyroiditis (AT) stands out as one of the most prevalent accompanying comorbidity of Multiple Sclerosis (MS). However, the specific impact of AT on the clinical course of MS is relatively unexplored. Objectives: The primary objective of this study is to determine the frequency of AT within an MS cohort and to assess its influence on the prognosis of MS. Method: We retrospectively detected those who had an AT diagnosis during their lifetime. Patients who had been diagnosed with AT before a diagnosis of MS or during the diagnosis process were analyzed for prognosis. (aMS) Demographic variables, baseline Expanded Disability Status Scale (EDSS) score and relapse number, disease- modifying treatment duration and type, the relapse number, new/expanding lesions in brain and spinal MRI in first five years, fifth-year EDSS and fifth year No Evidence of Disease Activitiy-3 results were collected. These variables were compared to people with MS who had similar baseline and demographic characteristics. (non-AT) Results: Fifty-seven people with MS (1.6 %) were diagnosed with AT, all of whom were female. Twenty-four of them were included in the prognosis analysis. There was no statistical difference between aMS and nonAT in diagnosis age, baseline relapse number and baseline EDSS score. (p > 0.05) There were no statistical differences in relapse number, MRI activity in five years, EDSS scores and NEDA-3 status in the fifth year. (P > 0.05) Conclusion: Comorbid AT is frequently seen in the MS population. It has a neutral effect on the MS course.Conference Object Cognitive Profiles of Relapsing Multiple Sclerosis Patients With Progression Independent of Relapse Activity Versus Non-NEDA Status(Sage Publications Ltd, 2025) Alizada, Said; Ozdogar, Asiye Tuba; Samadzade, Ulvi; Caliskan, Can; Ozakbas, SerkanConference Object Cognitive Stability Over Three Years Despite Loss of Ambulation in Progressive Multiple Sclerosis With Preserved Upper Limb Function(Sage Publications Ltd, 2025) Samadzade, Ulvi; Unal, Gozde Deniz; Caliskan, Can; Aydin, Esra; Ozakbas, SerkanConference Object Comparison of the Objective and Subjective Cognitive Fatigue During Relapse and Remission in Individuals With Multiple Sclerosis: Preliminary Results(Sage Publications Ltd, 2024) Ozakbas, Serkan; Yigit, Pinar; Kara, Irem; Samadzade, Ulvi; Ozdogar, Asiye TubaConference Object Determinants of Postpartum Relapse in Multiple Sclerosis: a Comprehensive Analysis of Demographic and Clinical Factors(Sage Publications Ltd, 2024) Alizada, Said; Samadzade, Ulvi; Yapici, Nurbanu; Kaya, Ergi; Ozdogar, Asiye Tuba; Ozakbas, SerkanConference Object Earlier Decline in Upper Limb Function Than Gait in Multiple Sclerosis: A Five-Year Longitudinal Study(Sage Publications Ltd, 2025) Unal, Gozde Deniz; Samadzade, Ulvi; Aydin, Esra; Caliskan, Can; Ozakbas, SerkanConference Object Elevated IgM Index Is Linked to More Severe Cognitive Impairment in Multiple Sclerosis(Sage Publications Ltd, 2025) Samadzade, Ulvi; Caliskan, Can; Unal, Gozde Deniz; Kara, Irem; Aydin, Esra; Ozakbas, SerkanConference Object Enhancing Fine Motor Assessment: The 9HPT-Extended as a Superior Alternative to the Standard 9HPT(Sage Publications Ltd, 2025) Unal, Gozde Deniz; Aydin, Esra; Caliskan, Can; Samadzade, Ulvi; Ozdogar, Asiye Tuba; Kahraman, Turhan; Ozakbas, SerkanConference Object Epilepsy Prevalence and Characteristics in Patients with Multiple Sclerosis: Implications for Disease Management(Sage Publications Ltd, 2024) Kaya, Ergi; Samadzade, Ulvi; Unal, Gozde Deniz; Zengin, Ela; Ozakbas, SerkanConference Object Evaluating the Ability of PDDS to Reflect Motor Function in Multiple Sclerosis: Comparison With EDSS and the Timed Up and Go Test(Sage Publications Ltd, 2025) Unal, Gozde Deniz; Caliskan, Can; Samadzade, Ulvi; Ozakbas, SerkanConference Object Evaluation of Disability in Individuals with Multiple Sclerosis Using Clinician-Rated and Patient-Reported Measures: A Cross-Sectional and Retrospective Study(Sage Publications Ltd, 2025) Caliskan, Can; Simsek, Yasemin; Samadzade, Ulvi; Ozakbas, SerkanConference Object Evaluation of Hepatitis B Virus Status in Patients Treated With Rituximab: A Retrospective Cohort Study(Sage Publications Ltd, 2025) Samadzade, Ulvi; Simsek, Yasemin; Ozakbas, SerkanConference Object Five Years of Ocrelizumab in MS: Clinical Stability and Subtle Cognitive Gains(Sage Publications Ltd, 2025) Ozakbas, Serkan; Samadzade, Ulvi; Unal, Gozde Deniz; Caliskan, Can; Kara, Irem; Alizada, SaidConference Object Five-Year Real-World Outcomes of Fingolimod in Multiple Sclerosis: Long-Term Effectiveness and Treatment Continuation Patterns(Sage Publications Ltd, 2025) Ozakbas, Serkan; Alizada, Said; Samadzade, Ulvi; Caliskan, CanConference Object A Generation Apart: Long-Term Outcomes of People with Multiple Sclerosis Diagnosed in the 1990s vs 2010s(Sage Publications Ltd, 2025) Ozakbas, Serkan; Samadzade, Ulvi; Simsek, Yasemin; Caliskan, CanConference Object Higher Body Mass Index Is Associated With Greater Physical Disability in Multiple Sclerosis: A Five-Year Prospective Study(Sage Publications Ltd, 2025) Samadzade, Ulvi; Kara, Irem; Ozakbas, SerkanConference Object How Much Damage Is Too Much? Early Predictors of Physical and Cognitive Decline After Treatment Switch in Multiple Sclerosis(Sage Publications Ltd, 2025) Ozdogar, Asiye Tuba; Samadzade, Ulvi; Ozakbas, SerkanConference Object Impact of Diagnosis and Treatment Timing on Long-Term Outcomes in Multiple Sclerosis: A Comprehensive Study(Sage Publications Ltd, 2024) Ozakbas, Serkan; Samadzade, Ulvi; Kara, Irem; Unal, Gozde Deniz[No Abstract Available]Conference Object Impact of Early Treatment Modification on Long-Term Outcomes in Treatment-Naive Multiple Sclerosis Patients: Adverse Reactions and Compliance Challenges(Sage Publications Ltd, 2024) Samadzade, Ulvi; Baba, Cavid; Simsek, Yasemin; Unal, Gozde Deniz; Kara, Irem; Ertekin, Ozge; Ozakbas, SerkanConference Object Longitudinal Impact of Fingolimod on Disease Course in Multiple Sclerosis: A Three-Year Pre- and Post-Treatment Analysis(Sage Publications Ltd, 2025) Alizada, Said; Samadzade, Ulvi; Caliskan, Can; Mammadov, Orkhan; Ozakbas, Serkan
